02/12/2019 /
In this study, long-term add-on cannabidiol treatment had an acceptable safety profile in patients with Lennox-Gastaut syndrome and led to sustained reductions in seizures.
02/11/2019 /
Subjects mostly favored “person-first” terminology (“person having epilepsy” and “person with epilepsy”), and 53.9% disapproved of the term “epileptic”.
02/11/2019 /
Zogenix, Inc. announced it has completed its rolling submission of a New Drug Application (NDA) to the FDA for FINTEPLA for the treatment of seizures associated with Dravet syndrome.
02/08/2019 /
Discover the latest about what’s happening at CURE and in our community in the February 2019 CURE Update from Chief Scientific Officer, Laura Lubbers!
02/08/2019 /
Lisuride, an anti-parkinson medicine with demonstrated anti-seizure effects, was able to stop epileptic activity in a model of convulsant Dravet syndrome zebrafish, researchers report.
02/08/2019 /
New research confirms that if spreading depolarization of neurons engages the brainstem, the result is fatal.
02/07/2019 /
This study presents the first evidence for the effectiveness of fenfluramine in reducing seizure incidence, severity, and seizure-induced respiratory arrest susceptibility in a mammalian SUDEP model.
02/07/2019 /
According to this retrospective analysis, higher concentrations of lactate and total protein as well as blood-brain barrier dysfunction are often seen after epileptic seizures vs mild pleocytosis and Ig synthesis.
02/06/2019 /
According to this population-based study, seizures in neonates seemed to play an important role in the development of epilepsy, intellectual disability and headache when covariates were observed to be equal.
